These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38691482)

  • 1. Therapeutic Drug Monitoring of Levetiracetam in Different Trimesters of Pregnant Women with Epilepsy in a Tertiary Care Center: A Prospective Study.
    Kumaravel J; Sarma P; Suri V; Singh P; Prakash A; Medhi B
    Neurol India; 2024 Mar; 72(2):358-363. PubMed ID: 38691482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies.
    Thangaratinam S; Marlin N; Newton S; Weckesser A; Bagary M; Greenhill L; Rikunenko R; D'Amico M; Rogozińska E; Kelso A; Hard K; Coleman J; Moss N; Roberts T; Middleton L; Dodds J; Pullen A; Eldridge S; Pirie A; Denny E; McCorry D; Khan KS
    Health Technol Assess; 2018 May; 22(23):1-152. PubMed ID: 29737274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring levetiracetam concentration in saliva during pregnancy is stable and feasible.
    Li W; Yang X; Chen Q; Wang Z; Duan Y; Chen L
    CNS Neurosci Ther; 2024 Jul; 30(7):e14827. PubMed ID: 38992878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring in pregnancy: Levetiracetam.
    Fallik N; Trakhtenbroit I; Fahoum F; Goldstein L
    Epilepsia; 2024 May; 65(5):1285-1293. PubMed ID: 38400747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Drug Monitoring of Antiepileptic Drugs in Women with Epilepsy Before, During, and After Pregnancy.
    Arfman IJ; Wammes-van der Heijden EA; Ter Horst PGJ; Lambrechts DA; Wegner I; Touw DJ
    Clin Pharmacokinet; 2020 Apr; 59(4):427-445. PubMed ID: 31912315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy.
    Voinescu PE; Park S; Chen LQ; Stowe ZN; Newport DJ; Ritchie JC; Pennell PB
    Neurology; 2018 Sep; 91(13):e1228-e1236. PubMed ID: 30185446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam use in pregnancy.
    Longo B; Forinash AB; Murphy JA
    Ann Pharmacother; 2009 Oct; 43(10):1692-5. PubMed ID: 19690219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
    Tan J; Paquette V; Levine M; Ensom MHH
    Clin Pharmacokinet; 2017 Nov; 56(11):1267-1285. PubMed ID: 28353057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing serum concentrations of levetiracetam in dogs with epilepsy.
    Saint-Maxent M; Juette T; Parent J; Castel A; Parmentier T
    J Vet Intern Med; 2024; 38(4):2249-2256. PubMed ID: 38888491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levetiracetam clearance associated with a breakthrough seizure in a pregnant patient receiving once/day extended-release levetiracetam.
    Garrity LC; Turner M; Standridge SM
    Pharmacotherapy; 2014 Jul; 34(7):e128-32. PubMed ID: 24807683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy.
    Reisinger TL; Newman M; Loring DW; Pennell PB; Meador KJ
    Epilepsy Behav; 2013 Oct; 29(1):13-8. PubMed ID: 23911354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
    Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
    Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.
    Spencer DD; Jacobi J; Juenke JM; Fleck JD; Kays MB
    Pharmacotherapy; 2011 Oct; 31(10):934-41. PubMed ID: 21950640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Variability During Long-Term Therapeutic Drug Monitoring of Valproate, Clobazam, and Levetiracetam in Patients With Dravet Syndrome.
    Johannessen Landmark C; Heger K; Lund C; Burns ML; Bjørnvold M; Sætre E; Johannessen SI
    Ther Drug Monit; 2020 Oct; 42(5):744-753. PubMed ID: 32558674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Albani F; Riva R; Baruzzi A
    Ther Drug Monit; 2004 Aug; 26(4):375-9. PubMed ID: 15257066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
    Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam use during pregnancy in women with epilepsy: Preliminary observations from a tertiary care center in Northern India.
    Bansal R; Suri V; Chopra S; Aggarwal N; Sikka P; Saha SC; Goyal MK; Kumar P
    Indian J Pharmacol; 2018; 50(1):39-43. PubMed ID: 29861526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of levetiracetam concentration in peripheral blood mononuclear cells with clinical efficacy: A sensitive monitoring biomarker in patients with epilepsy.
    Harby SA; Nassra RA; Mekky JF; Ali SM; Ismail CA
    Seizure; 2020 May; 78():71-77. PubMed ID: 32213443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam plasma level monitoring during pregnancy, delivery, and postpartum: clinical and outcome implications.
    López-Fraile IP; Cid AO; Juste AO; Modrego PJ
    Epilepsy Behav; 2009 Jul; 15(3):372-5. PubMed ID: 19362602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levetiracetam clearance and breakthrough seizure in a pregnant patient successfully handled by intensive therapeutic drug monitoring.
    Cappellari AM; Cattaneo D; Clementi E; Kustermann A
    Ther Drug Monit; 2015 Jun; 37(3):285-7. PubMed ID: 25384117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.